ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 324 filers reported holding ARRAY BIOPHARMA INC in Q2 2019. The put-call ratio across all filers is 1.86 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $585,000 | -64.4% | 23,986 | -75.5% | 0.04% | -47.8% |
| Q2 2018 | $1,645,000 | -64.8% | 98,086 | -65.7% | 0.07% | -64.4% |
| Q1 2018 | $4,672,000 | +137.3% | 286,317 | +21.7% | 0.19% | +80.8% |
| Q2 2017 | $1,969,000 | -29.6% | 235,352 | -24.8% | 0.10% | -19.4% |
| Q1 2017 | $2,796,000 | +536.9% | 312,852 | +525.7% | 0.13% | +396.2% |
| Q4 2016 | $439,000 | +124.0% | 50,000 | +71.8% | 0.03% | -58.7% |
| Q3 2016 | $196,000 | -79.4% | 29,100 | -89.1% | 0.06% | +34.0% |
| Q2 2016 | $950,000 | +14.5% | 266,988 | -5.2% | 0.05% | +27.0% |
| Q1 2016 | $830,000 | -63.9% | 281,668 | -48.3% | 0.04% | -66.1% |
| Q4 2015 | $2,297,000 | +194.5% | 544,368 | +217.9% | 0.11% | +275.9% |
| Q3 2015 | $780,000 | +88.9% | 171,258 | +198.6% | 0.03% | +107.1% |
| Q2 2015 | $413,000 | +24.8% | 57,358 | -21.1% | 0.01% | -17.6% |
| Q2 2014 | $331,000 | -53.2% | 72,683 | -51.8% | 0.02% | -55.3% |
| Q1 2014 | $708,000 | -44.2% | 150,723 | -40.5% | 0.04% | -43.3% |
| Q4 2013 | $1,269,000 | -18.8% | 253,399 | +0.8% | 0.07% | -21.2% |
| Q3 2013 | $1,562,000 | +314.3% | 251,265 | +202.5% | 0.08% | +608.3% |
| Q2 2013 | $377,000 | – | 83,074 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 15,978,580 | $268,121,000 | 9.11% |
| BVF INC/IL | 4,672,195 | $78,399,000 | 7.65% |
| First Light Asset Management, LLC | 2,391,575 | $40,131,000 | 6.25% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 694,500 | $11,647,000 | 4.47% |
| Copernicus Capital Management, LLC | 286,797 | $4,812,000 | 3.49% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 225,511 | $3,784,000 | 3.00% |
| SECTORAL ASSET MANAGEMENT INC | 1,566,477 | $26,285,000 | 2.94% |
| X-Square Capital, LLC | 173,802 | $2,917,000 | 2.18% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 2,618,654 | $43,941,000 | 1.48% |
| Birchview Capital, LP | 128,000 | $2,148,000 | 1.46% |